GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avalo Therapeutics Inc (STU:C6K0) » Definitions » Cyclically Adjusted Book per Share

Avalo Therapeutics (STU:C6K0) Cyclically Adjusted Book per Share : €303.07 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Avalo Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Avalo Therapeutics's adjusted book value per share for the three months ended in Mar. 2025 was €10.475. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €303.07 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-05-29), Avalo Therapeutics's current stock price is €3.10. Avalo Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €303.07. Avalo Therapeutics's Cyclically Adjusted PB Ratio of today is 0.01.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Avalo Therapeutics was 0.02. The lowest was 0.01. And the median was 0.01.


Avalo Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Avalo Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalo Therapeutics Cyclically Adjusted Book per Share Chart

Avalo Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -807.82 -183.87

Avalo Therapeutics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -646.60 -598.42 -525.33 -183.87 303.07

Competitive Comparison of Avalo Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Avalo Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avalo Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avalo Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Avalo Therapeutics's Cyclically Adjusted PB Ratio falls into.


;
;

Avalo Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Avalo Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=10.475/134.9266*134.9266
=10.475

Current CPI (Mar. 2025) = 134.9266.

Avalo Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201506 -690.333 100.684 -925.116
201509 -9,756.667 100.392 -13,113.002
201512 4,003.667 99.792 5,413.250
201603 2,658.333 100.470 3,570.005
201606 1,652.667 101.688 2,192.870
201609 174.333 101.861 230.924
201612 65.333 101.863 86.540
201703 -99.500 102.862 -130.516
201706 558.000 103.349 728.492
201709 2,062.111 104.136 2,671.840
201712 2,140.182 104.011 2,776.314
201803 1,812.455 105.290 2,322.628
201806 1,370.917 106.317 1,739.830
201809 1,194.143 106.507 1,512.784
201812 6.400 105.998 8.147
201903 7.124 107.251 8.962
201906 5.452 108.070 6.807
201909 5.760 108.329 7.174
201912 6.576 108.420 8.184
202003 18.120 108.902 22.450
202006 35.005 108.767 43.424
202009 25.520 109.815 31.356
202012 15.736 109.897 19.320
202103 21.622 111.754 26.105
202106 542.970 114.631 639.101
202109 878.538 115.734 1,024.227
202112 523.795 117.630 600.818
202203 147.667 121.301 164.254
202206 -144.359 125.017 -155.802
202209 -52.513 125.227 -56.581
202212 -264.205 125.222 -284.681
202303 -106.418 127.348 -112.751
202306 -110.897 128.729 -116.236
202309 17.168 129.860 17.838
202312 8.352 129.419 8.707
202403 -100.133 131.776 -102.527
202406 -12.226 132.554 -12.445
202409 1.961 133.029 1.989
202412 12.132 133.157 12.293
202503 10.475 134.927 10.475

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Avalo Therapeutics  (STU:C6K0) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Avalo Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.10/303.07
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Avalo Therapeutics was 0.02. The lowest was 0.01. And the median was 0.01.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Avalo Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Avalo Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Avalo Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
540 Gaither Road, Suite 400, Rockville, MD, USA, 20850
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Avalo Therapeutics Headlines

No Headlines